Prospective Cohort Study on Predicting the Progression of Diabetic Microangiopathy Using Multimodal Eye Imaging
Not yet recruitingOBSERVATIONAL
Enrollment
250
Participants
Timeline
Start Date
January 1, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2028
Conditions
Diabetic Retinopathy
Trial Locations (1)
100191
Peking University Third Hospital, Beijing
All Listed Sponsors
lead
Peking University Third Hospital
OTHER
NCT06727955 - Prospective Cohort Study on Predicting the Progression of Diabetic Microangiopathy Using Multimodal Eye Imaging | Biotech Hunter | Biotech Hunter